pubmed-article:18421212 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18421212 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:18421212 | lifeskim:mentions | umls-concept:C0538727 | lld:lifeskim |
pubmed-article:18421212 | lifeskim:mentions | umls-concept:C0017725 | lld:lifeskim |
pubmed-article:18421212 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
pubmed-article:18421212 | lifeskim:mentions | umls-concept:C0031139 | lld:lifeskim |
pubmed-article:18421212 | lifeskim:mentions | umls-concept:C0205554 | lld:lifeskim |
pubmed-article:18421212 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
pubmed-article:18421212 | lifeskim:mentions | umls-concept:C0031928 | lld:lifeskim |
pubmed-article:18421212 | lifeskim:mentions | umls-concept:C0678640 | lld:lifeskim |
pubmed-article:18421212 | lifeskim:mentions | umls-concept:C0332169 | lld:lifeskim |
pubmed-article:18421212 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:18421212 | pubmed:dateCreated | 2008-5-27 | lld:pubmed |
pubmed-article:18421212 | pubmed:abstractText | The use of dextrose-containing solutions in peritoneal dialysis (PD) is thought to be associated with glucose-related toxicity both to the peritoneal membrane and systemically. There has, therefore, been considerable interest in minimizing the use of dextrose exposure during PD. The present study was designed to explore the use of icodextrin in patients with high/high-average transporter characteristics for two exchanges per day to minimize glucose exposure. | lld:pubmed |
pubmed-article:18421212 | pubmed:language | eng | lld:pubmed |
pubmed-article:18421212 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18421212 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18421212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18421212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18421212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18421212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18421212 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18421212 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18421212 | pubmed:issn | 1421-9735 | lld:pubmed |
pubmed-article:18421212 | pubmed:author | pubmed-author:FinkelsteinFr... | lld:pubmed |
pubmed-article:18421212 | pubmed:author | pubmed-author:SantacroceSal... | lld:pubmed |
pubmed-article:18421212 | pubmed:author | pubmed-author:GobinJayaJ | lld:pubmed |
pubmed-article:18421212 | pubmed:author | pubmed-author:FernandoSanja... | lld:pubmed |
pubmed-article:18421212 | pubmed:copyrightInfo | Copyright 2008 S. Karger AG, Basel. | lld:pubmed |
pubmed-article:18421212 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18421212 | pubmed:volume | 26 | lld:pubmed |
pubmed-article:18421212 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18421212 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18421212 | pubmed:pagination | 279-83 | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:meshHeading | pubmed-meshheading:18421212... | lld:pubmed |
pubmed-article:18421212 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18421212 | pubmed:articleTitle | The utility of two daytime icodextrin exchanges to reduce dextrose exposure in automated peritoneal dialysis patients: a pilot study of nine patients. | lld:pubmed |
pubmed-article:18421212 | pubmed:affiliation | Hospital of St. Raphael, New Haven, CT 06511, USA. | lld:pubmed |
pubmed-article:18421212 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18421212 | pubmed:publicationType | Clinical Trial | lld:pubmed |